Fund HoldingsMerck & Co., Inc.

Total Portfolio Value
$276.28M
Total Bought
$0
Total Sold
$2.58M
Net Transaction
-$2.58M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
PERSONALIS INC(PSNL)14,044,94314,044,943091,573111,79840.47%+20,225
KYMERA THERAPEUTICS INC(KYMR)772,165772,165043,70560,08221.75%+16,378
MODERNA INC(MRNA)2,308,1902,308,190059,62168,06924.64%+8,448
ENTRADA THERAPEUTICS INC1,739,7681,739,768010,09117,8856.47%+7,794
EVAXION BIOTECH A/S1,214,1261,214,12604,5655,7912.10%+1,226
VIRIDIAN THERAPEUTICS INC(VRDN)93,41493,41402,0162,9071.05%+891
SUTRO BIOPHARMA INC2,723,509272,351-2,451,1582,3653,1511.14%+786
TUHURA BIOSCIENCES13,95013,950035110.00%-24
NEUPHORIA THERAPEUTICS INC10,02710,0270118390.01%-79
XILIO THERAPEUTICS INC1,483,7581,483,75801,2509500.34%-300
CARISMA THERAPEUTICS INC1,473,2401,473,2400404630.02%-340
LAVA THERAPEUTICS NV1,149,3450-1,149,3451,7930-1,793
ALECTOR INC3,545,7193,545,719010,4955,5312.00%-4,964
Page 1 of 1